Status:
COMPLETED
Evaluating the Relationship Between Sleep-Disordered Breathing and Daytime Alertness
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Sleep Apnea, Obstructive
Eligibility:
All Genders
18+ years
Brief Summary
Obstructive sleep apnea (OSA) is a serious sleep disorder in which a person repeatedly stops breathing, or experiences shallow breathing for short periods of time during sleep. Daytime sleepiness is a...
Detailed Description
Individuals with OSA can experience up to 300 sleep disruptions each night, which may result in excessive daytime sleepiness (EDS), one of the most common symptoms of OSA. EDS can have serious consequ...
Eligibility Criteria
Inclusion
- Experiences symptoms of OSA, including snoring and sleepiness
- Stable medical history with no change in medications that could affect sleepiness
Exclusion
- Suspected diagnosis of a sleep disorder other than OSA (i.e., periodic leg movements, narcolepsy, insomnia, central sleep apnea, sleep hypoventilation syndrome)
- Medically unstable health conditions (e.g., heart attack, congestive heart failure)
- Use of psychotropic medications that cause sedation in the 3 months prior to study entry
- Recent or confirmed history of recreational drug use or alcohol abuse
- Pregnant
- Inability to communicate verbally, write, or read
- Visual, hearing, or cognitive impairment
Key Trial Info
Start Date :
October 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT00393913
Start Date
October 1 2006
End Date
May 1 2011
Last Update
August 5 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Sleep Disorders Center
New York, New York, United States, 10016